In the latest development in the biosimilars market, in September, the European Medicines Agency granted its first approval for a monoclonal antibody biosimilar. IMS Health estimates that biosimilar sales in markets that are highly regulated totaled around $700 million in 2011 and will account for about 2% of the total biotech market by 2016. According […]
The shutdown of the US federal government that began October 1, is having a wide spread impact on science and research. In addition to worker furloughs, researchers cannot access their labs, travel to meetings, or engage in fieldwork. Some extramural researchers report they are also unable to complete fieldwork. Grant processing, reviews and meetings have […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
